Average cost of care in year after ovarian cancer surgery around $100K

November 9, 2017

(HealthDay)—For women with ovarian cancer who underwent both surgery and adjuvant chemotherapy, the average medical expenditures are about $100,000 in the first year after surgery, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Alexandra S. Bercow, M.D., from Columbia University College of Physicians and Surgeons in New York City, and colleagues conducted a of women with diagnosed from 2009 to 2012 who underwent both surgery and . Medical expenditures were estimated for a 12-month period beginning on the date of surgery; all payments, including out-of-pocket costs, were examined. Data were included for 5,031 women after exclusion of patients with incomplete insurance enrollment or coverage, those who did not undergo chemotherapy, and those with capitated plans.

The researchers found that during the first year after the index procedure, the median total medical expenditures per patient were $93,632. Inpatient services accounted for 37.8 percent in expenditures ($30,708); outpatient services for 58.3 percent ($52,700); and outpatient drug costs for 3.8 percent ($1,814). The median out-of-pocket expense was $2,998, which included $1,509, $589, and $351 for outpatient services, inpatient services, and outpatient drug costs, respectively.

"The average cost of care for women with ovarian cancer in the first year after surgery is approximately $100,000. Patients bear approximately 3 percent of these costs in the form of out-of-pocket expenses," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further: New VTE often occurs during chemo in ovarian cancer

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New VTE often occurs during chemo in ovarian cancer

May 11, 2017
(HealthDay)—For patients with ovarian cancer, new diagnosis of venous thromboembolism frequently occurs during neoadjuvant or adjuvant chemotherapy, according to a study published in the June issue of Obstetrics and Gynecology.

Surgery, chemo best for elderly with advanced ovarian cancer

December 29, 2015
(HealthDay)—Primary debulking surgery and chemotherapy in an optimal timeframe is associated with the longest survival time for elderly women with advanced ovarian cancer, according to a study published in the January issue ...

Five-year risk of repeat SUI, POP surgery less than 10 percent

May 23, 2017
(HealthDay)—For women undergoing surgery for stress urinary incontinence (SUI) and pelvic organ prolapse (POP), the risk of repeat procedures is less than 10 percent, with increased risks for older women and initial POP ...

Kidney disease patients have higher out-of-pocket costs than stroke and cancer patients

January 17, 2017
Patients who have chronic kidney disease but are not on dialysis have higher out-of-pocket healthcare expenses than even stroke and cancer patients, according to a study by researchers at Loyola University Chicago and Loyola ...

More women choose breast reconstruction after mastectomy

October 13, 2017
(HealthDay)—Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows.

Survival similar with debulking by laparotomy, laparoscopy

April 10, 2017
(HealthDay)—For women with epithelial ovarian cancer, three-year survival rates are similar for women undergoing debulking by laparotomy or laparoscopy, according to a study published in the May issue of Obstetrics & Gynecology.

Recommended for you

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

New treatment helps avoid deafness in child chemotherapy patients

June 21, 2018
An international trial has found that a medicine commonly used to treat poisoning is effective in reducing deafness in children receiving chemotherapy for cancer.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

thomasct
not rated yet Nov 09, 2017
See my comment under today's heading.. Cancer drug parity laws lower costs for many, but not everyone.. an learn how to prevent 98% and cure most, based on over 1/2million reproducible bio-resonance tests.by Dr H R Clark PhD ND.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.